Comparative Pharmacology
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 4 25 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
Head-to-head clinical analysis: DIANEAL 137 W DEXTROSE 4 25 IN PLASTIC CONTAINER versus INPERSOL ZM W DEXTROSE 4 25 IN PLASTIC CONTAINER.
DIANEAL 137 W/ DEXTROSE 4.25% IN PLASTIC CONTAINER vs INPERSOL-ZM W/ DEXTROSE 4.25% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Intraperitoneal administration of Dianeal with 4.25% dextrose creates an osmotic gradient across the peritoneal membrane, promoting ultrafiltration and removal of uremic toxins and excess fluid.
Provides osmotic gradient for peritoneal dialysis; glucose and icodextrin facilitate ultrafiltration and removal of waste products across the peritoneal membrane.
Intraperitoneal administration: 2 liters infused over 10-20 minutes, dwell time 4-6 hours, then drain over 15-20 minutes; 4 exchanges per 24 hours.
2 L intraperitoneally via an indwelling peritoneal catheter, dwell time 4-6 hours, 4 exchanges per day
None Documented
None Documented
Dextrose: approximately 1.5–2 hours (systemic half-life in renal impairment; peritoneal equilibration half-life for dextrose in dialysate is 1–2 hours, reflecting absorption).
Not applicable as a traditional half-life; removal is dependent on peritoneal dialysis dwell time and membrane transport characteristics. Effective clearance half-life during dialysis is approximately 2-4 hours depending on exchange schedule.
Peritoneal dialysis: Dextrose is metabolized systemically and eliminated primarily as CO2. Unchanged dextrose undergoes renal elimination only in anuric patients on dialysis, with minimal biliary/fecal excretion (<2%).
Primarily removed via peritoneal dialysis; minimal renal excretion (less than 5% unchanged). Dextrose is metabolized to CO2 and water. Biliary/fecal excretion negligible.
Category C
Category C
Peritoneal Dialysis Solution
Peritoneal Dialysis Solution